Apr 17 |
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor
|
Apr 16 |
New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
|
Apr 11 |
Myriad Genetics (MYGN) Announces Favorable Research Results
|
Apr 9 |
Myriad Genetics Research Shows Reduction in Hospitalizations for Patients with Depression after GeneSight Testing
|
Mar 29 |
Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?
|
Mar 28 |
Why Is Myriad (MYGN) Down 1% Since Last Earnings Report?
|
Mar 27 |
Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay
|
Mar 22 |
Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date
|
Mar 20 |
Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device
|